Active Pharmaceutical Ingredients
We have developed our product range of niche, small-molecule API’s to meet the growing demands of the pharmaceutical industry. We actively research and innovate in order to bring new API’s to market in order to support our customers.
Standard API’s
Amisulpride
Main Therapeutic Application: Antipsychotics agent/ Neuroleptic agent
CAS-RN: 71675-85-9
Betahistine Dihydrochloride
Main Therapeutic Application: Antivertigo agent - agonist of histamine
CAS-RN: 5579-84-0
Betahistine Dimesilate
Main Therapeutic Application: Antivertigo agent - agonist of histamine
CAS-RN: 54856-23-4
Dibrompropamidine Isetionate
Main Therapeutic Application: Disinfectant/ Antiseptic
CAS-RN: 614-87-9
Histamine Dihydrochloride
Main Therapeutic Application: Immunostimulants/ Antineoplastic agent/ Diagnostic agent
CAS-RN: 56-92-8
Histamine Diphosphate Monohydrate
Main Therapeutic Application: Diagnostic Agent
CAS-RN: 51-74-1
Picloxidine Dihydrochloride
Main Therapeutic Application: Antiseptic agent
CAS-RN: 19803-62-4
Propamidine Isetionate
Main Therapeutic Application: Antiseptic agent topical
CAS-RN: 140-63-6
Sulpiride
Main Therapeutic Application: Antipsychotic agent/ Neuroleptic agent
CAS-RN: 15676-16-1
Tiapride Hydrochloride
Main Therapeutic Application: Antipsychotic agent/ Neuroleptic agent
CAS-RN: 51012-33-0
Are you looking for
other molecules?
For more information about our R&D pipeline and CDMO services
ContactProducts Pipeline
Research and development with purpose
We have an active R&D department, and a diverse
range of analysis and regulatory services.
The regulatory environment is more challenging than ever and pharmaceutical companies demand more than just API production.
Our clients need partners with the expertise to help them achieve their business goals at the right speed and quality level.
We build relationships based on trust and brand prestige. At LEBSA, we work every day to continually improve our processes. We also actively research and innovate in order to bring new API’s to market and support our API pharma customers.